Tatva Chintan Pharma Chem posts consolidated Q3 FY26 at Rs. 15.16 Cr
News

Tatva Chintan Pharma Chem posts consolidated Q3 FY26 at Rs. 15.16 Cr

Tatva Chintan Pharma Chem has reported total income of Rs. 133.06 crore during the period ended December 31, 2025

  • By IPP Bureau | January 21, 2026

Tatva Chintan Pharma Chem Ltd has reported consolidated financial results for the period ended December 31, 2025.

Tatva Chintan Pharma Chem has posted net profit of Rs. 15.16 crore for the period ended December 31, 2025 as against net profit of Rs. 9.91 crore for the period ended September 30, 2025. The company posted net profit of Rs. 0.13 crore for the period ended December 31, 2024.

Tatva Chintan Pharma Chem has reported total income of Rs. 133.06 crore during the period ended December 31, 2025 as compared to Rs. 124.52 crore during the period ended September 30, 2025. The company reported total income of Rs. 85.94 crore during the period ended December 31, 2024.

For the 9 months period ended December 31, 2025, Tatva Chintan Pharma Chem has reported total income of Rs. 375.61 crore during the 9 months period ended December 31, 2025 as compared to Rs. 276.05 crore during the 9 months period ended December 31, 2024.

The company has posted net profit of Rs. 31.73 crores for the 9 months period ended December 31, 2025 as against net profit of Rs. 4.68 crore for the 9 months period ended December 31, 2024.

Other Related stories

Startup

Digitization

India is becoming centre of innovation and global execution: Sanjay Vyas, President and MD, Parexel India
India is becoming centre of innovation and global execution: Sanjay Vyas, President and MD, Parexel India
Sanjay Vyas President and Managing Director, Parexel India And Global SBU Head- Safety services & Logistics, Parexel International